Neurocrine Biosciences shares owned by Sendero Wealth Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Sendero Wealth Management
from 13F filings
Historical chart of Sendero Wealth Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Sendero Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Sendero Wealth Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.7M | 20k | 137.92 |
| 2023-12-31 | $2.6M | 20k | 131.76 |
| 2023-09-30 | $2.2M | 20k | 112.50 |
| 2023-06-30 | $1.4M | 15k | 94.30 |
| 2023-03-31 | $1.6M | 16k | 101.22 |
| 2022-12-31 | $1.8M | 15k | 119.44 |
| 2022-09-30 | $1.4M | 14k | 106.18 |
| 2022-06-30 | $1.3M | 13k | 97.48 |
| 2022-03-31 | $1.0M | 11k | 93.71 |
| 2021-12-31 | $958k | 11k | 85.16 |